Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2007
10/31/2007CN101062920A Processes for the preparation of pesticidal compounds and novel intermediates thereof
10/31/2007CN101062919A 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/30/2007US7288662 Process for the preparation of eletriptan
10/30/2007US7288660 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
10/30/2007US7288652 Method for preparing oltipraz
10/30/2007US7288651 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288542 viricides; therapy for genetic engineered virus; polymerase inhibitor
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007CA2421548C Amidine inhibitors of serine proteases
10/30/2007CA2416212C Indole derivatives useful for the treatment of cns disorders
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007121466A2 Process for preparing rimonabant
10/25/2007WO2007121390A1 Process for making cytokine inhibiting compounds containing 4- and 5- imidazolyl rings and the intermediates thereof
10/25/2007WO2007121280A1 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/25/2007WO2007120669A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007WO2007120595A2 Amines for the treatment of hcv
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007119998A1 Diimidazole compound and organic electroluminescent device using the same
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007WO2007119246A2 An improved process for the manufacture of losartan potassium
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118589A1 Substituted diamino-1,3,5,-triazines, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/25/2007WO2007098270A3 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
10/25/2007WO2007017890A3 Process for preparation of pantoprazole sodium sesquihydrate and product prepared therby
10/25/2007US20070249847 Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof
10/25/2007US20070249846 Biofuel
10/25/2007US20070249840 Process for the preparation of bis-benzazolyl compounds
10/25/2007US20070249705 N-(1-(2,3-Dihydro-1H-Inden-5Yl)-2-Oxo-3-Pyrrolidinyl)-Sulfonamide Derivatives for Use as Factor Xa Inhibitors
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249678 Synthesis and uses of pyroglutamic acid derivatives
10/25/2007US20070249662 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole; chemical intermediates for safer oxidation of the thioether intermediate to give the sulfinyl derivative, omeprazole; ("prazoles", antisecretory agents); by-product inhibition
10/25/2007US20070249658 Pyrrolo[3,2-C]Pyridine Deriatives and Processes for the Preparation Thereof
10/25/2007US20070249649 Inhibitors of c-fms kinase
10/25/2007US20070249642 Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione
10/25/2007US20070249624 4-squarylpiperazine derivatives such as 3-(1-Piperazinyl)-4-(2-thienyl)-cyclobut-2-ene-1,2-dione with other an AIDS antiviral agent, antiinfective agent, an immunomodulator, and HIV entry inhibit; viricide; human immunodeficiency virus-1 (HIV) and acquired immunodeficiency syndrome (AIDS)
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249609 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/25/2007US20070249607 Nk-1 and serotonin transporter inhibitors
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249589 Novel diazepan derivatives
10/25/2007US20070249587 Aromatic-Ring-Fused Pyrimidine Derivative
10/25/2007US20070249584 N-[(S)-1-(4-benzyl)-2-oxoperhydroazepin-3-yl]-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8-methyldec-6-enamide; N-[(S)-1-(3-amino-1H-indazol-5-ylmethyl)-2-oxoperhydroazepin-3-yl]-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8-methyldec-6-enamide;anticancer agents
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007CA2650401A1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007CA2649927A1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648216A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007CA2647266A1 Process for making cytokine inhibiting compounds containing 4- and 5- imidazolyl rings and the intermediates thereof
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/24/2007EP1847570A1 Colorant, ink, ink-jet ink, method of ink-jet recording, color toner, and color filter
10/24/2007EP1847539A1 Quinazoline derivatives
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1846399A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
10/24/2007EP1846398A1 Alkinyl-oxypyrimidine used in the form of pesticides
10/24/2007EP1846396A2 Substituted 4-(indol-3-yl)quinazolines and their use
10/24/2007EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
10/24/2007EP1845991A2 Substituted 5-phenyl pyrimidines i in therapy
10/24/2007EP1567010B1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061108A New 4-benzimidazolyl-3(2h)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101060842A Chemical compounds
10/24/2007CN101058572A Peptides compound with antineoplastic activity
10/24/2007CN101058567A Novel pharmacology acceptable salt for cinepazide
10/24/2007CN101058566A Novel medicinal salt for cinepazide and preparation method thereof
10/24/2007CN101058565A Stable cinepazide water-soluble salt
10/24/2007CN101058561A Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof
10/24/2007CN100344626C Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives
10/24/2007CN100344625C Method for preparing candestartan
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285663 Bis(pyrimidinylidene)bisisoindolylidenes, e.g., 3,3'-Bis(1,3-diethyl-2-thio-4,6-dioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene; uses include ink-jet printing, color filters and optical storage media
10/23/2007US7285569 Tricycles, their manufacture and use as pharmaceutical agents
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/23/2007US7285554 Pyrazole derivative
10/23/2007US7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285550 Triazolotriazines and pyrazolotriazines and methods of making and using the same
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/18/2007WO2007117607A2 Quinazolines for pdk1 inhibition
10/18/2007WO2007117565A2 Standardization of processes for culturing primary cells
10/18/2007WO2007117401A2 Indoles and benzoimidazoles as modulators of the histamine h4 receptor
10/18/2007WO2007117399A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007116092A1 Enzyme inhibitors
10/18/2007WO2007115999A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 626